Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients

International Journal of Obesity

Volumn 25, Issue 8, 2001, Pages 1101-1107

  Nam, S Y ^a   Kim, K R ^a   Cha, B S ^a   Song, Y D ^a   Lim, S K ^a   Lee, H C ^a   Huh, K B ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Growth hormone; Insulin resistance; Type 2 diabetes mellitus; Visceral fat

Indexed keywords

EUTROPIN; FATTY ACID; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOMATOMEDIN C;

ADULT; ARTHRALGIA; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EDEMA; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL THERAPY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LOW CALORY DIET; MALE; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY;

EID: 0034901778     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801636     Document Type: Article

References (40)

1. Risk factors for developing non-insulin dependent diabetes: A 10 years follow up on men in Uppsala
2. Biology of regional body fat distribution: Relationship to non-insulin-depedent diabetes mellitus
3. Contribution of intra-abdominal fat accumulation to the impairement of glucose and lipid metabolism in human obesity
4. The triumvirate; β-cell, muscle, liver: A collusion responsible for NIDDM
5. Insulin-stimulated entry of glucose into muscle in vivo as a major factor in the regulation of blood glucose
6. Sleep-related growth hormone secretion in human obesity: Effect of dietary treatment
7. Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity
8. Insulin resistance and obesity: The role of fat distribution pattern
9. Weight loss during fasting: Implication for the obese
10. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects
11. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent
12. The effect of growth hormone on glucose metabolism and insulin secretion in man
13. Effects of growth hormone on insulin action in man
14. Insulin resistace in acromegaly: Defects in both hepatic and extrahepatic insulin action
15. Peripheral glucose metabolism in acromegaly
16. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults
17. Computer nutrient analysis software packages: Consideration for selection
18. Obesity: New insight into the anthropometric classification of fat distribution shown by computed tomography
19. Glucose clamp technique: A method for quantifying insulin secretion and resistance
20. Effect of long-term rhGH administration in GH-dependent adults on fat cell epinephrine response
21. Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats
22. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children
23. Cardiovascular effects of growth hormone treatment in growth hormone deficient adults: Stimulation of the renin-aldosterone system
24. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
25. Effects of diet and physical activity on adiposity and body fat distribution: Implications for the prevention of cardiovascular disease
26. Insulin resistance and body fat distribution
27. Effects of fatty acids on glucose production and utilization in man
28. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects
29. Abdominal obesity as important component of insulin-resistance syndrome
30. Pathophysiology and pathogenesis of visceral fat obesity
31. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women
32. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: A minimal model analysis
33. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
34. Energy expenditure and body composition in growth hormone deficient adults on exogenous growth hormone
35. Resting metabolic rate, body composition and related hormonal parameters in growth hormone-deficient adults before and after growth hormone replacement therapy
36. Growth hormone administration in addition to a very low caloric diet and an exercise program in obese subjects
37. Human growth hormone treatment of hypophysectomized rats increases the proportion of type-I fibers in skeletal muscle
38. Comparative effects of IGF-1 and insulin on the glucose transporter system in rat muscle
39. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors
40. Growth hormone and hepatic lipoprotein metabolism